The doctors in the child neurology division are preparing a report on her health condition that they plan to publish soon.

The reports from the doctors said that the 11-year-old child was found with Covid-19 infection induced Acute Demyelinating Syndrome (ADS). The nerves are covered with a protective layer called myelin that helps messages from the brains move quickly and smoothly through the body.

ADS include health conditions that damage myelin, brain signals and affect a gamut of neurological functions such as vision, muscle movement, senses, bladder and bowel movement etc.

The child was undergoing treatment and the condition was improved with immunotherapy and she was discharged from the hospital after about 50% of her vision was regained.

AIIMS authorities are also treating another Covid-19-positive teenager (13) girl after she had complained of fever and encephalopathy (swelling of brain). She is undergoing treatment and the doctors are still trying to ascertain whether her condition was induced by Covid-19.

Epilepsy, encephalitis, Kawasaki-like disease, Guillain-barre syndrome etc are the other common health complications that children, who tested Covid-19 positive, are known to suffer from.

Some of these brain conditions may adversely affect the long-term neurodevelopment. Hence these children need a regular follow-up treatment that can be a challenge for a country such as India where adequate resource is lacking.

The post First case of COVID-19 linked brain nerve damage in a child reported appeared first on The Gulf Indians.

“Sushant death is a case of suicide. Murder completely ruled out,” Dr Sudhir Gupta said.

The panel of AIIMS doctors was re-evaluating Sushant Singh Rajput’s post-mortem and viscera report based on the 20 per cent viscera sample available with them. The forensic agencies have examined a laptop, two hard disks, a canon camera and two mobile phones.

The 34-year old movie star was found dead on June 14 in his Mumbai apartment. Though the Mumbai police, based on the autopsy, called it suicide, Sushant Singh Rajput’s family raised doubts that became a part of an overall CBI investigation.

The AIIMS doctors had submitted their findings to the Central Bureau of Investigation (CBI) on September 29. Earlier Cooper Hospital, where Sushant Singh Rajput autopsy was conducted found that the actor’s death was a case of suicide. The circumstantial evidences also point it to be a case of suicide, ruling out any foul play.

The CBI will be continuing its probe from the angle of a suicide, particularly the abetment of suicide angle. It has been 57 days since CBI began probe of SSR’s death case.

The post AIIMS report rules out Sushant Singh Rajput murder theories appeared first on The Gulf Indians.

Expressing his gratitude to the Delhi Police for this initiative he said, “It is very sad that a dozen Delhi police personnel died due to Corona. In spite of these casualties, they are doing a great job deploying personnel to contain the spread, while the number of containment zones has jumped from 200 to 600.”

दान अर्थात देने का भाव, अर्पण करने की निष्काम भावना।#AIIMS, Delhi में #plasmadonation Campaign में #PlasmaWarriors @DelhiPolice के जवानों ने #plasma donate कर साबित कर दिया कि दिल्ली पुलिस सचमुच 'दिल की पुलिस' है। इस Campaign का शुभारंभ आज मैंने किया।@HMOIndia
@AmitShah pic.twitter.com/6JBar6xwYL

— Dr Harsh Vardhan (@drharshvardhan) July 19, 2020

The Minister saluted the contribution of these volunteers by conferring certificates to 26 Police constables. Of these, Shri Om Prakash was donating his plasma for the third time today.  The Union Minister stated that these donations will have a long-lasting impact on other countrymen who will get inspired to donate their plasma. Every single donor counts in our journey towards victory over COVID-19 and we need more and more of these plasma warriors to help fight the pandemic till a definitive treatment or vaccine is developed, he added.

He acknowledged the huge potential of this strategy and the government’s will to tap into it. He commented, “As of now convalescent plasma therapy has been approved for compassionate use with various plasma banks being set up to ensure round the clock availability. Despite the fact that India has one of the highest cure rates amongst COVID-19 patients, the plasma donations has yet to pick up. I am happy that AIIMS, New Delhi is organising this plasma donation campaign with the support of Delhi Police Corona Warriors.”

Plasma from recovered COVID-19 patients contains protective antibodies to the novel SARS-CoV-2 virus. It can provide immunity to patients of Covid-19 when transfused.  Considering its potential benefit, plasma therapy is provided to those patients who are not responding to conventional treatment. Anyone who has recovered from COVID-19, and has completed 28 days after the completion of treatment or home isolation, is between 18 to 60 years of age with a weight of more than 50 kg is eligible to donate their blood plasma.
The Blood Bank will assess their eligibility for blood donation and check the level of COVID-19 protective antibody levels in their blood before they can donate. The blood of a survivor usually has a high concentration of such antibodies and when given to a susceptible person, these antibodies circulate in blood, reach tissues and neutralize the virus. The process of donation is completed in one to three hours and plasma can be collected on same day.

More than 23,600 people cured in India

Proactive measures of Central and State/UT governments of aggressive testing and timely diagnosis has helped in detecting cases early. Effective clinical management of the moderate and severe cases through a well-executed Standard of Care protocol has ensured high rate of recovery among the COVID patients.

The last 24 hours saw a sharp increase of 23,672 COVID patients recovering. The gap between recovered patients and active COVID-19 cases has further increased to 3,04,043. The total number of recovered cases is 6,77,422. The recovery rate as of now is at 62.86%.

Medical attention is being provided to all the 3,73,379 active cases, in hospitals and home isolation.

The country’s testing infrastructure has been substantially ramped up. The testing strategy prescribed by ICMR allows all registered medical practitioners to recommend testing. The Rapid Antigen Point of Care (POC) Test coupled with the facilitation of widespread gold-standard RT-PCR based testing by States/UTs has resulted in a surge in the number of samples tested. 3,58,127 samples have been tested in the last 24 hours. With total of 1,37,91,869 samples tested the testing per million (TPM) for India has reached 9994.1.

Consistently expanding diagnostic lab network comprises of 1262 labs, including 889 labs in the government sector and 373 private labs.

The post Harsh Vardhan flags off plasma donation campaign appeared first on The Gulf Indians.

Considering the unmet medical needs to treat COVID-19, Drugs Controller General of India, Dr V G Somani, approved monoclonal antibody injection Itolizumab, an already approved drug of Biocon, for restricted emergency use for the treatment of “cytokine” release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19, they said.

“The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee comprising pulmonologists, pharmacologists and medicine experts from AIIMS, among others, for treatment of cytokine release syndrome,” an official was quoted as saying.

“It is already an approved drug of Biocon for treating psoriasis for last many years,” the official said.

Written informed consent of each patient is required before the use of this drug, he said.

The post Drugs controller’s nod to use psoriasis injection to treat COVID cases appeared first on The Gulf Indians.